New insights from DAPA-CKD indicate dapagliflozin modulates key pathways related to kidney outcomes
Listen to this summary
The authors aimed to elucidate the mechanisms by which dapagliflozin improves kidney outcomes in patients with chronic kidney disease (CKD) by analyzing plasma proteomics. Their findings revealed that dapagliflozin modifies key pathways associated with CKD progression, particularly those related to inflammation and fibrosis, thereby supporting its protective effects on kidney health.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Kidney international
View all →Aug 5, 2026 · Kidney international
Heme-induced kallikrein-kinin system activation in hemolytic uremic syndrome
Jul 28, 2026 · Kidney international
Better Guidelines, Better Patient Lives: A Sustainable Partnership Model for Integrating Lived Experience into Clinical Guideline Development
Jul 28, 2026 · Kidney international
ISN International Expert Forum: Exploring the Nexus of Cardiovascular-Kidney-Metabolic (CKM) Health
Jul 27, 2026 · Kidney international
A multi-national study examined the response sustainability to calcineurin inhibitors and long-term kidney survivals in children with genetic podocytopathies
Jul 27, 2026 · Kidney international
Early Acute T Cell-Mediated Rejection and Kidney Allograft Outcomes
Jul 27, 2026 · Kidney international
Secondary Thrombotic Microangiopathy (TMA) in children- A Central Role for the Glycocalyx
More in Internal Medicine
View all →Aug 9, 2026 · American heart journal
Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial
Aug 8, 2026 · JACC. Clinical electrophysiology
LMNA Deficiency Reveals a Role for SK3 Channel Dysfunction in Atrioventricular Block
Aug 8, 2026 · JACC. Clinical electrophysiology
Atrial Fibrillation Initiation Arises From Reentry at Patient-Specific Regions With Steep Repolarization Gradients Identified During Sinus Rhythm
Aug 7, 2026 · American heart journal
HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics
Aug 7, 2026 · The American journal of medicine
Consumption of Ultra-Processed Foods and Increased Risks of Prostate Cancer in a Random Sample of United States Adults
Aug 7, 2026 · JACC. Clinical electrophysiology
The Emergence of Sports Electrophysiology: Care of Athletes With Arrhythmias, From the ACC's Sports and Exercise Cardiology Leadership Council
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
